Lifenet Insurance Company

DB:7XJ Stock Report

Market Cap: €894.8m

Lifenet Insurance Valuation

Is 7XJ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7XJ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 7XJ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 7XJ's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7XJ?

Key metric: As 7XJ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 7XJ. This is calculated by dividing 7XJ's market cap by their current earnings.
What is 7XJ's PE Ratio?
PE Ratio23.4x
EarningsJP¥6.13b
Market CapJP¥143.45b

Price to Earnings Ratio vs Peers

How does 7XJ's PE Ratio compare to its peers?

The above table shows the PE ratio for 7XJ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.7x
WUW Wüstenrot & Württembergische
25.3x34.6%€1.1b
NBG6 NÜRNBERGER Beteiligungs-AG
13.5x38.8%€562.2m
RLV RheinLand Holding
11.8xn/a€111.4m
DFV DFV Deutsche Familienversicherung
20.1xn/a€84.6m
7XJ Lifenet Insurance
23.4x7.9%€143.4b

Price-To-Earnings vs Peers: 7XJ is expensive based on its Price-To-Earnings Ratio (23.4x) compared to the peer average (17.7x).

Price to Earnings Ratio vs Industry

How does 7XJ's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
7XJ 23.4xIndustry Avg. 11.8xNo. of Companies13PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 7XJ is expensive based on its Price-To-Earnings Ratio (23.4x) compared to the European Insurance industry average (12.1x).

Price to Earnings Ratio vs Fair Ratio

What is 7XJ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7XJ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio23.4x
Fair PE Ratio8x

Price-To-Earnings vs Fair Ratio: 7XJ is expensive based on its Price-To-Earnings Ratio (23.4x) compared to the estimated Fair Price-To-Earnings Ratio (8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 7XJ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€10.80
€12.50
+15.8%
6.2%€13.28€11.73n/a2
Dec ’25€12.30
€12.50
+1.7%
6.2%€13.28€11.73n/a2
Nov ’25€11.70
€11.35
-3.0%
4.1%€11.82€10.88n/a2
Oct ’25€9.80
€11.35
+15.8%
4.1%€11.82€10.88n/a2
Sep ’25€10.70
€8.50
-20.5%
27.3%€10.82€6.18n/a2
Aug ’25€9.95
€7.67
-23.0%
23.1%€9.43€5.90n/a2
Jul ’25€10.00
€7.67
-23.3%
23.1%€9.43€5.90n/a2
Jun ’25€8.25
€7.67
-7.1%
23.1%€9.43€5.90n/a2
May ’25€8.15
€7.72
-5.3%
23.1%€9.50€5.94n/a2
Apr ’25€8.85
€7.94
-10.2%
23.1%€9.78€6.11n/a2
Mar ’25€8.10
€8.43
+4.1%
19.2%€9.87€6.17n/a3
Feb ’25€7.55
€7.78
+3.0%
16.7%€9.46€6.31n/a3
Jan ’25€7.35
€7.78
+5.8%
16.7%€9.46€6.31n/a3
Dec ’24€6.55
€7.78
+18.7%
16.7%€9.46€6.31€12.303
Nov ’24€5.75
€7.78
+35.3%
16.7%€9.46€6.31€11.703
Oct ’24€6.00
€8.51
+41.8%
11.1%€9.45€7.56€9.802
Sep ’24€6.20
€8.51
+37.2%
11.1%€9.45€7.56€10.702
Aug ’24€6.65
€9.04
+35.9%
11.1%€10.04€8.03€9.952
Jul ’24€6.70
€9.04
+34.9%
11.1%€10.04€8.03€10.002
Jun ’24€6.30
€9.04
+43.4%
11.1%€10.04€8.03€8.252
May ’24€7.70
€9.99
+29.7%
3.4%€10.33€9.64€8.152
Apr ’24€7.80
€9.99
+28.0%
3.4%€10.33€9.64€8.852
Mar ’24€7.65
€10.10
+32.1%
3.4%€10.45€9.76€8.102
Feb ’24€9.55
€8.26
-13.5%
8.3%€8.95€7.57€7.552
Jan ’24€8.15
€8.26
+1.3%
8.3%€8.95€7.57€7.352
Dec ’23€7.50
€8.26
+10.1%
8.3%€8.95€7.57€6.552

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 12:27
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lifenet Insurance Company is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shinichiro NakamuraBofA Global Research
Kazuki WatanabeDaiwa Securities Co. Ltd.
Toru KoboriMarusan Securities Co. Ltd.